We are live on ! Find out more
GCM

Gables Capital Management Portfolio holdings

AUM $236M
1-Year Est. Return 32.91%
This Fund
S&P 500
This Quarter Est. Return
+16.95%
1 Year Est. Return
+32.91%
3 Year Est. Return
+123.38%
5 Year Est. Return
+165.74%
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$9.51M
Cap. Flow
-$6.31M
Cap. Flow %
-5.08%
Top 10 Hldgs %
27.65%
Holding
393
New
16
Increased
39
Reduced
93
Closed
35

Top Buys

Rank Stock Value
1
MJ icon
Amplify Alternative Harvest ETF
MJ
+$278K
2
NKE icon
Nike
NKE
+$192K
3
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$171K
4
FCX icon
Freeport-McMoran
FCX
+$169K
5
LYFT icon
Lyft
LYFT
+$145K

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.06M
2
GE icon
GE Aerospace
GE
+$955K
3
META icon
Meta Platforms (Facebook)
META
+$886K
4
AAPL icon
Apple
AAPL
+$551K
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$488K

Sector Composition

Rank Sector Weight
1 Financials 14.53%
2 Communication Services 12.79%
3 Healthcare 11.76%
4 Consumer Discretionary 11.75%
5 Industrials 9.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UPV icon
326
ProShares Ultra FTSE Europe
UPV
$14M
$3K ﹤0.01%
60
– –
NS
327
DELISTED
NuStar Energy L.P.
NS
$3K ﹤0.01%
100
-300
-75% -$7.76K
CX icon
328
Cemex
CX
$17.1B
$2K ﹤0.01%
464
– –
GGN
329
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$770M
$2K ﹤0.01%
502
– –
HPE icon
330
Hewlett Packard
HPE
$66.5B
$2K ﹤0.01%
140
-95
-40% -$1.46K
LILA icon
331
Liberty Latin America Class A
LILA
$1.69B
$2K ﹤0.01%
169
– –
LILAK icon
332
Liberty Latin America Class C
LILAK
$1.67B
$2K ﹤0.01%
126
– –
NRG icon
333
NRG Energy
NRG
$29.2B
$2K ﹤0.01%
55
– –
OLN icon
334
Olin
OLN
$2.12B
$2K ﹤0.01%
82
– –
REZI icon
335
Resideo Technologies
REZI
$5.49B
$2K ﹤0.01%
87
-2
-2% -$44
APTO
336
DELISTED
Aptose Biosciences, Inc.
APTO
$2K ﹤0.01%
2
– –
AVNS
337
DELISTED
Avanos Medical
AVNS
$1K ﹤0.01%
12
-12
-50% -$537
DMAC icon
338
DiaMedica Therapeutics
DMAC
$351M
$1K ﹤0.01%
125
– –
DNR
339
DELISTED
Denbury Resources, Inc.
DNR
$1K ﹤0.01%
300
– –
BLPH
340
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$1K ﹤0.01%
93
– –
AEF
341
abrdn Emerging Markets Equity Income Fund
AEF
$361M
$0 ﹤0.01%
6
– –
APH icon
342
Amphenol
APH
$201B
– –
-132
Closed -$3K
ASIX icon
343
AdvanSix
ASIX
$542M
$0 ﹤0.01%
13
-6
-32% -$183
BBH icon
344
VanEck Biotech ETF
BBH
$398M
– –
-150
Closed -$17K
BKNG icon
345
Booking.com
BKNG
$149B
– –
-25
Closed -$2K
BOND icon
346
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.43B
$0 ﹤0.01%
1
– –
BSV icon
347
Vanguard Short-Term Bond ETF
BSV
$44.6B
$0 ﹤0.01%
1
– –
BXMX
348
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
– –
-1,600
Closed -$19K
CCI icon
349
Crown Castle
CCI
$33.5B
– –
-91
Closed -$10K
CFG icon
350
Citizens Financial Group
CFG
$30.7B
– –
-492
Closed -$15K
12 13
14
15 16

Similar funds

RP
Raelipskie Partnership Waterloo, Ontario, Canada $236M AUM 19.33% 1-Year Est. Return
CWL
Causey Wealth LLC Greenwood Village, Colorado $236M AUM 14.5% 1-Year Est. Return
WW
Windle Wealth Oklahoma City, Oklahoma $237M AUM 22.79% 1-Year Est. Return
TCM
Tekne Capital Management New York $237M AUM 62.98% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
JRPCML
J. R. Prunier Capital Management LLC Holden, Massachusetts $235M AUM
CF
CNA Financial Chicago, Illinois $235M AUM 3.39% 1-Year Est. Return
BCM
Birmingham Capital Management Birmingham, Alabama $237M AUM 32.7% 1-Year Est. Return

Gables Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Gables Capital Management held 393 positions worth $124M, up 8.3% from $115M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Gables Capital Management withdrew a net $6.31M in Q1 2019, closing 35 positions and reducing 93 holdings. Its most notable exit was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019, an estimated $96K position sold in full.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, Gables Capital Management opened a new position in GW Pharmaceuticals Plc American Depositary Shares worth $194K.

  • Gables Capital Management's largest Q1 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,150 shares worth $194K.
  • Gables Capital Management added most to Amplify Alternative Harvest ETF in Q1 2019, an estimated $278K increase.
  • Gables Capital Management's biggest Q1 2019 reduction was ExxonMobil, cutting an estimated $1.06M.
  • Gables Capital Management fully exited iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019 in Q1 2019, selling an estimated $96K.
  • Gables Capital Management's ten largest holdings make up 28% of its $124M portfolio in Q1 2019.
  • Gables Capital Management opened 16 new positions and closed 35 in Q1 2019.
  • Gables Capital Management's portfolio value rose 8.3% quarter-over-quarter to $124M.

Based on Gables Capital Management's 13F filing for Q1 2019, filed 30 Apr 2019.